NDT Advance Access originally published online on April 21, 2006
Nephrology Dialysis Transplantation 2006 21(8):2290-2291; doi:10.1093/ndt/gfl164
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Brief Report
Bovine ureter graft for haemodialysis access surgery*
Department of Cardiovascular Surgery,
zmir Ataturk Training and Research Hospital,
zmir, Turkey
Correspondence and offprint requests to: Bilgin Emrecan, 20. sok No: 26/5, 06490-Bahçelievler-Ankara, Turkey. Email: bilginemrecan@yahoo.com
Keywords: bovine ureter graft; haemodialysis; vascular access
| The first 10% of the full text of this article appears below. |
Bovine ureter SynerGraft (SG) (CryoLife, Inc.) has been recently introduced into haemodialysis access surgery. It is a non-glutaraldehyde fixed acellular collagen and elastin matrix conduit that may withstand arterial pressures. There has only been one published report in humans with this graft for vascular access, except for a canine model which Matsuura et al. reported [1]. In this study, we report the early and mid-term outcome of bovine ureter as a haemodialysis access graft in chronic haemodialysis.
Four female patients with